AMGN — Bearish (ASignal Rank 4/4)
ASignal's 10+ AI agent pipeline rates AMGN as Bearish with 77% confidence in the Healthcare sector.
AI Analysis Summary
Amgen (AMGN) presents significant downside risks due to extreme leverage, overvaluation, and deteriorating technicals. The stock is forecasted to decline ~10% over 6 months.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade C — 50/100
- Bill Ackman (Activist Investing): Grade C — 52/100
- Ray Dalio (Macro/Risk Parity): Grade C — 55/100
Consensus: Bearish
Price Intelligence
- Current price: $344.55
- Price target: $341.06 (-1%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: good
- Competitive moat: intangible assets
Peer Group Analysis
AMGN is in the “High ROE Quality” cluster alongside SYY, SPG, NTAP, MSI, MAS (23 stocks total). 0 of 23 peers are currently bullish.